MARKET

MIRM

MIRM

Mirum Pharmaceuticals
NASDAQ
109.16
+2.28
+2.13%
Pre Market: 108.50 -0.66 -0.60% 08:43 05/14 EDT
OPEN
108.00
PREV CLOSE
106.88
HIGH
114.99
LOW
107.42
VOLUME
18
TURNOVER
0
52 WEEK HIGH
114.99
52 WEEK LOW
42.89
MARKET CAP
6.66B
P/E (TTM)
-8.0238
1D
5D
1M
3M
1Y
5Y
1D
MIRUM PHARMACEUTICALS INC <MIRM.O>: LEERINK PARTNERS RAISES TARGET PRICE TO $154 FROM $150
Reuters · 9h ago
BUZZ-U.S. STOCKS ON THE MOVE -Fervo, Sensata Technologies, Akamai
Reuters · 19h ago
BUZZ-U.S. STOCKS ON THE MOVE-Chipmakers, Dynatrace, Alibaba
Reuters · 20h ago
BUZZ-Mirum Pharma dips on $600 mln convertible bond sale
Reuters · 1d ago
Mirum Pharmaceuticals prices $600M senior notes
Seeking Alpha · 1d ago
MIRUM PHARMACEUTICALS PRICES $600.0 MILLION CONVERTIBLE SENIOR NOTES OFFERING; REFINANCES A PORTION OF 2029 CONVERTIBLE NOTES
Reuters · 1d ago
Mirum Pharmaceuticals announces $600M convertible senior notes offering
TipRanks · 1d ago
Mirum Pharmaceuticals Announces Proposed $600M Offering Of Notes Due 2032
Benzinga · 1d ago
More
About MIRM
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the treatment of rare diseases affecting children and adults. It has three medicines: LIVMARLI (maralixibat) oral solution (Livmarli), Cholbam (cholic acid) capsules, and Chenodal or Ctexli (chenodiol) tablets. Livmarli is an orally administered, minimally-absorbed ileal bile acid transporter (IBAT) inhibitor (IBATi) that is used for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) in the United States and various other countries and for cholestatic pruritus in patient with progressive familial intrahepatic cholestasis (PFIC) in the United States, Canada and Japan. Cholbam is used for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders. The Company is also advancing its product candidate, volixibat, for the treatment of adult patients with cholestatic liver diseases.

Webull offers Mirum Pharmaceuticals Inc stock information, including NASDAQ: MIRM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MIRM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MIRM stock methods without spending real money on the virtual paper trading platform.